Assembly and disassembly of protein-protein complexes needs to be dynamically controlled and phosphoswitches based on linear motifs are crucial in this process. Extracellular signal-regulated kinase 2 (ERK2) recognizes a linearbinding motif at the C-terminal tail (CTT) of ribosomal S6 kinase 1 (RSK1), leading to phosphorylation and subsequent activation of RSK1. The CTT also contains a classical PDZ domain-binding motif which binds RSK substrates (e.g. MAGI-1). We show that autophosphorylation of the disordered CTT promotes the formation of an intramolecular charge clamp, which efficiently masks critical residues and indirectly hinders ERK binding. Thus, RSK1 CTT operates as an autoregulated phosphoswitch: its phosphorylation at specific sites affects its protein-binding capacity and its conformational dynamics. These biochemical feedbacks, which form the structural basis for the rapid dissociation of ERK2-RSK1 and RSK1-PDZ substrate complexes under sustained epidermal growth factor (EGF) stimulation, were structurally characterized and validated in living cells. Overall, conformational changes induced by phosphorylation in disordered regions of protein kinases, coupled to allosteric events occurring in the kinase domain cores, may provide mechanisms that contribute to the emergence of complex signaling activities. In addition, we show that phosphoswitches based on linear motifs can be functionally classified as ON and OFF protein-protein interaction switches or dimmers, depending on the specific positioning of phosphorylation target sites in relation to functional linear-binding motifs. Moreover, interaction of phosphorylated residues with positively charged residues in disordered regions is likely to be a common mechanism of phosphoregulation.
Assembly and disassembly of protein-protein complexes needs to be dynamically controlled and phosphoswitches based on linear motifs are crucial in this process. Extracellular signal-regulated kinase 2 (ERK2) recognizes a linearbinding motif at the C-terminal tail (CTT) of ribosomal S6 kinase 1 (RSK1), leading to phosphorylation and subsequent activation of RSK1. The CTT also contains a classical PDZ domain-binding motif which binds RSK substrates (e.g. MAGI-1). We show that autophosphorylation of the disordered CTT promotes the formation of an intramolecular charge clamp, which efficiently masks critical residues and indirectly hinders ERK binding. Thus, RSK1 CTT operates as an autoregulated phosphoswitch: its phosphorylation at specific sites affects its protein-binding capacity and its conformational dynamics. These biochemical feedbacks, which form the structural basis for the rapid dissociation of ERK2-RSK1 and RSK1-PDZ substrate complexes under sustained epidermal growth factor (EGF) stimulation, were structurally characterized and validated in living cells. Overall, conformational changes induced by phosphorylation in disordered regions of protein kinases, coupled to allosteric events occurring in the kinase domain cores, may provide mechanisms that contribute to the emergence of complex signaling activities. In addition, we show that phosphoswitches based on linear motifs can be functionally classified as ON and OFF protein-protein interaction switches or dimmers, depending on the specific positioning of phosphorylation target sites in relation to functional linear-binding motifs. Moreover, interaction of phosphorylated residues with positively charged residues in disordered regions is likely to be a common mechanism of phosphoregulation.
Introduction
Regulation of cellular physiology is based on dynamic protein networks: the activity of network components and their protein-protein interaction capacity are continuously changing depending on extracellular stimuli. Protein phosphorylation is often used as a mechanism by which protein complex activity and assembly could be directly affected [1] . For example, mitogen-activated kinases (MAPK) involved in the regulation of cell growth, death or differentiation form complexes with their partner proteins that are dependent on signaling pathway activation [2] . Interestingly, protein-protein interactions relevant for signaling, particularly those mediated by protein kinases, are mediated by so-called linear motifs. These protein regions do not adopt a welldefined three-dimensional structure on their own [3, 4] . Although the role of protein phosphorylation occurring in specific regions of a structured domain could be well-explained by allosteric mechanisms, for linear motif-based interactions, this is not that well-explored [5] . Linear-binding motifs may change their proteinbinding capacity upon phosphorylation, but mechanistic insights into how these 'phosphoswitches' affect protein network level modalities (e.g. signaling amplitude or dynamics) are still lacking. Intriguingly, the Ras/ERK cell growth promoting pathway -activated by epidermal growth factor (EGF) -displays interesting dynamic properties [6, 7] . However, the molecular principles and the structural basis of rapid biochemical feedbacks, which do not involve transcriptional level regulation and are normally dependent on fast posttranslational modifications, are not well-understood.
RSK1 is a member of the MAPK-activated protein kinase (MAPKAPK) family and is one of the downstream effector kinases of the Ras/ERK signaling pathway whose activity is directly controlled by extracellular signal-regulated kinases (ERK) [8] . RSKs contain two kinase domains: a C-terminal regulatory (CAMK-type) kinase domain (CTKD) and an Nterminal effector (AGC-type) kinase domain (NTKD) [9] (Fig. 1A ). ERK2 forms a complex with RSK1 in which the activation loop of the CTKD becomes phosphorylated at Thr573 [10] . Importantly, there is an autophosphorylation site at the RSK1 CTT (Ser732), which has a role in the dissociation of the ERK-RSK binary complex [11] . The activated CTKD of RSK1 autophosphorylates the linker connecting the two kinase domains at Ser380, recruiting phosphoinositide-dependent kinase 1 (PDK1), which then phosphorylates the activation loop of NTKD at Ser221 [12] . Ultimately, the activated NTKD will phosphorylate RSK substrates.
The C terminus of RSK contains multiple overlapping linear motifs: in addition to the ERK-binding site (often referred to as a MAPK docking motif) and its own autophosphorylation site, the calcium-binding S100B protein also binds to the CTT [13] (Fig. 1B) . The N-terminal part of the CTT contains the inhibitory segment (696-709) that adopts a helical conformation and blocks the CTKD substrate-binding pocket [14] . ERK phosphorylation at the CTKD activation loop renders this inhibitory segment disordered, but this likely does not influence the tight binding of ERK2 to RSK1 (K D % 0.1 lM) [10, 15] (Fig. 1C) .
The last residues of RSKs contain a structurally uncharacterized class I PDZ substrate motif (class I consensus motif: X[ST]X [VL] ) that also contains the Ser732 autophosphorylation site (Fig. 1C) . RSK2 was previously identified as a PDZ-binding partner of scaffold/anchor proteins (Shank1, MAGI-1, GRIP, and SNX27), which may all get phosphorylated by the recruited kinase [16, 17] . Similarly, RSK1 also has two known PDZ-binding partners (MAGI-1 and EBP50) [16, 18] . Some of these proteins (e.g. Shank and EBP50) were indeed shown to be RSK substrates, but there are many putative RSK phosphorylation sites in other binding partners as well. RSK substrates without PDZ domains usually overlap with other AGC kinase substrates; therefore, RSK seems to be a relatively low specificity kinase [19] . Since PDZ containing substrates specifically interact with RSKs, they could represent a highly specific RSK phosphorylation target group and these interactions could also be important in the precise subcellular trafficking of RSK1.
Membrane-associated guanylate kinase with inverted domain structure proteins (MAGI) are nuclear or tight junction-associated scaffolds and RSK substrate proteins with tumor suppressor functions [20] . MAGI-3 was shown to be a regulator of the b2-adrenergic receptor or lysophosphatidic acid induced ERK2 activation [21, 22] . All MAGI proteins contain six PDZ domains, two WW domains and an inactive guanylate kinase domain. RSK was shown to be an interaction partner of the second PDZ domain of MAGI-1. This PDZ domain is one of the few domains that may prefer Leu at the C terminus from the class I group with an optimal sequence of RxxTLL [23] . Moreover, there are seven identified phosphosites in the C-terminal tail of MAGI-1 conferring to a RSK AGC kinase-type phosphorylation consensus motif ([RK]xRxx[ST]) [24, 25] .
Here, we demonstrate the regulated and dynamic nature of ERK2-RSK1 and RSK1-MAGI-1 complexes in live cells following Ras/ERK signaling pathway stimulation. Autophosphorylation, PDZ, and MAPK binding all target the 40-residue-long, disordered C-terminal tail of RSK1, and our findings are in good agreement with the decreased ERK2-binding capacity of RSK1 observed after Ras/ERK pathway activation in cells [11] . In summary, our results provide a biochemical and structural basis underlying ERK signaling dynamics and feedback mechanisms: Ras-ERK pathway activation influences RSK-PDZ substrate interaction and activator MAP kinase binding by using an autoregulatory phosphoswitch located in the disordered RSK C-terminal tail.
Results
In vitro phosphorylation of full-length RSK1 Activated ERK phosphorylates RSK1 at specific sites triggering a hierarchical set of further phosphorylation events involving both kinase domains of RSK and PDK1, which will ultimately promote cell growth. In order to clarify the In the lower panel, the ERK2 bound state of RSK1 is presented where important residues are shown by stick representation (PDB ID: 4NIF). The conserved last seven residues of RSK1 is invisible in this crystal structure.
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The FEBS Journal 285 (2018) 46-71 ª 2017 Federation of European Biochemical Societies role of individual phosphorylation events, we first investigated the in vitro phosphorylation pattern of RSK1 under controlled conditions. We produced recombinant fulllength RSK1 (FL-RSK1), active ERK2, and PDK1 kinases. RSK1 or a mixture of RSK1 and upstream kinases were incubated in the presence of ATP, and then we searched for RSK1 phosphopeptides using mass spectrometry (MS). We could reproduce most known phosphorylation sites [24, 26] (Fig. 2A) . All major phosphosites can be associated with the complex activation mechanism of RSK1 except for the C-terminal autophosphorylation sites. Here, Ser732 was the main phosphorylated site, but we could also detect both Thr733 and Thr734 phosphorylated peptides. These latter CTT autophosphorylation sites might be mutually exclusive because no double or triple phosphorylated peptides were observed.
Since autophosphorylation of the CTT had been formerly attributed to the activity of the NTKD [11, 12] , we wanted to further clarify the role of the CTKD as our data indicated this enzymatic domain to be important for CTT phosphorylation. We constructed a constitutively active CTKD by introducing a phospho-mimicking mutation into the activation loop (T573E mutation). In kinase assays where the phosphorylation of a RSK1 substrate peptide (containing the phosphosite Ser380) was monitored in trans, autophosphorylation of the CTKD was also prominent (Fig. 2B) . Further MS analysis identified that Ser732 was highly phosphorylated in this sample. We were also able to phosphorylate isolated C-terminal RSK1 peptides with the same construct, where again Ser732 was phosphorylated selectively (Fig. 2C ). In conclusion, we provide evidence that the C-terminal autophosphorylation site (Ser732) of RSK1 is preferentially phosphorylated by the CTKD and not by the NTKD.
RSK1 binds to the second PDZ domain of MAGI-1 via its C terminus
Next, we wanted to address the biochemical relevance of Ser732 autophosphorylation, particularly in terms of RSK-partner protein binding. Formerly, a yeast twohybrid screen identified an interaction between the second PDZ domain of MAGI-1 (325-577) and RSK1 [16] . We initiated a quantitative characterization of this interaction using purified PDZ protein and a chemically synthesized seven amino acid long RSK1 peptide. Unexpectedly, a fluorescence polarization-based protein-peptide-binding assay could not be used to measure PDZ-RSK1 peptide binding as no change in the fluorescence polarization signal (or fluorescence intensity) was detected when PDZ domain concentration was increased in the presence of fixed amount of labeled RSK1 peptides (712-735 or 729-735) (Fig. 3A) .
However, this does not prove that the protein and the labeled peptide fail to interact, as the N-terminal fluorescent group may remain highly uncoordinated even if the PDZ domain binds to the C terminus of the peptide. Therefore, microscale thermophoresis (MST) was used and a~20 lM interaction was detected (Fig. 3B) . With competitive titration experiments, we could also show that phosphorylation at the major C-terminal autophosphorylation site (Ser732) does not influence the steady-state-binding affinity of the CTT peptide (729-735) to the second PDZ domain of MAGI-1 (Fig. 3C ).
Phosphorylation at Ser732 affects ERK2-RSK1 (CTT) binding RSK1 binds to ERK2 with a MAPK-binding linear motif located in the CTT. Interestingly, ERK2-binding affinity to the RSK1 peptide decreased five-fold (from 0.2 lM to 1 lM) when the peptide was phosphorylated at Ser732 (Fig. 3D ). This five-fold affinity decrease was further confirmed using two different CTT peptide lengths (Fig. 3E,F) , and a similar decrease in affinity was observed in the presence of an excess (100 lM) of MAGI-1 PDZ domain (Fig. 3H) . Because of the lack of any fluorescence anisotropy change upon PDZ binding, we were also able to measure the binding affinity of ERK2 to RSK1 CTT in the presence of large amount of MAGI-1 PDZ domain (Fig. 3G) . Interestingly, PDZ domain binding affected ERK2-RSK1 CTT affinity only moderately indicating that a ternary complex can form between the MAPK, MAPKAPK, and a PDZ domain containing substrate (Fig. 3I) .
The crystal structure of the ERK2-RSK1(CTT) protein-peptide complex had been formerly determined [10, 15, 27] . However, the C-terminal region following the MAPK docking motif was disordered (729-735) in that structure (Fig. 1C ), preventing the observation of possible contacts between the autophosphorylatable Ser732 and the ERK2 interaction surface. Nonetheless, we observed here that Ser732 phosphorylation lowered ERK2-RSK1(CTT)-binding affinity. Therefore, we reasoned that some extra residues outside of the MAPK linear motif may play a role in ERK-RSK binding. Unrestrained FlexPepDock simulations [28] were used to investigate the potential conformations of the ERK2 bound state (Fig. 4A ). This ab initio modeling suggested that ERK2 bound CTT may mediate an additional contact via Lys729. To validate this putative interaction in vitro, the ERK2-binding affinity of a truncated RSK1 peptide containing only the core of the MAPK-binding linear motif (which is visible in the crystal structure of the protein-peptide complex) was measured. As expected, the binding strength decreased (more than seven-fold) (Fig. 4B) . Moreover, replacing Lys729 with alanine (K729A) generated a comparable decrease in binding affinity, while an alanine substitution at Ser732 did not affect ERK2 binding (Fig. 4C) . In conclusion, Lys729 is likely involved in a transient interaction in the ERK2 bound state, which was invisible in the crystal structure. In phosphorylated CTT, Lys729 may interact with the phosphate group via electrostatic interactions. This intramolecular charge clamp would prevent the formation of a presumably transient interaction between the CTT and ERK2 and will lead to weakened binding [11] .
Crystal structure solution of RSK1 CTT peptide-MAGI-1 PDZ domain complexes
In order to structurally characterize RSK CTT and PDZ domain binding, we set out to determine the highresolution structure of the RSK1 peptide-MAGI-1 PDZ domain complex by X-ray crystallography. As expected, the bound RSK1 peptide shows a canonical class I PDZ domain-binding mode (Fig. 5A ) [29] . The PDZ ligand peptide adopts an antiparallel b-sheet conformation and mediates several main chain directed interactions augmenting the b2 strand of the PDZ domain. The C-terminal Leu735 fits into the hydrophobic pocket of the PDZ domain, Thr734 (at position À1) does not mediate interaction, while Thr733 (at position À2) faces toward His530 creating the canonical hydrogen bond interaction of class I PDZ ligands [29] . Ser732 is also in hydrogen bond distance (2.9 A) to Lys499. The C terminus of human papillomavirus (HPV) E6 interacts with a set of tumor suppressor proteins such as MAGI-1, and the structure of this PDZ-peptide ligand complex had been formerly reported [30, 31] . X-ray structure solution revealed that the E6 peptide and the RSK1 peptide studied herein display a similar core-binding mode (Fig. 5A ). The main interaction is mediated by (a) the C-terminal Leu forming main chain-specific bonds as well as hydrophobic contacts; (b) a Thr residue at position À2 forming a hydrogen bond with His530 from the PDZ domain; (c) a side chain-specific hydrogen bond between the hydroxyl group of the Ser at À3 position and Lys499 of MAGI-1. The HPV E6 peptide was reported to bind with greater affinity to the MAGI-1 PDZ domain (K D~1 lM) compared with the RSK1 peptide. This could be best explained by the fact that E6 mediates more extensive contacts, which are additional to the core interactions typical for class I peptides [31] .
We also solved crystal structures with phosphorylated CTT peptides (pSer732) and captured the MAGI-1-pRSK1 (CTT) complex in two slightly different crystal forms (Fig. 5B) . The phospho-serine rotamer was different between the two crystal structures, although both conformations were compatible with the pSer732-Lys499 hydrogen bond (2.7-3.5
A) since the lysine side chain rotamer also changed (Fig. 5B) . In summary, the CTT phosphorylation at Ser732 is compatible with PDZ binding, while phosphorylation at Thr733 would very likely disrupt RSK1-PDZ (MAGI-1) binding due to steric hindrance within the binding pocket.
Experimental evidence for the intramolecular charge clamp in phosphorylated CTT
Next, we used isothermal calorimetry (ITC) for the biophysical characterization of the binding of the C-terminal RSK1 peptide (CTT) to the PDZ domain from MAGI-1 (Fig. 6 ). Unexpectedly, this type of analysis suggested that the structure of the CTT may greatly change upon phosphorylation. First, the thermodynamic parameters of complex formation with RSK1 696-735 or RSK1 729-735 and with their phosphorylated Ser732 forms were analyzed at 37°C (Fig. 6A ). The parameters of the native RSK1 peptide binding were comparable to that of HPV E6 peptide binding to the same PDZ construct [32] . In contrast to this moderately exothermic binding, the longer phosphorylated peptide showed an endothermic reaction under the same temperature. Moreover, the seven-residue-long RSK1 729-73 phospho-peptide also showed exothermic binding. In order to investigate this discrepancy and to eliminate a possible experimental artifact, we repeated Fig. 2 . RSK1 phosphopeptide mapping and characterization of autophosphorylation at the C-terminal tail. (A) RSK1 or its ERK2 and PDK1 activated form was analyzed with mass spectrometry. The identified phosphosites are highlighted with red labels for each sample. Sites essential in RSK1 activation are marked in bold. The mock sample contained CTKD autophosphorylation sites (380, 732, 733, 735) because of the weak intrinsic activity of unphosphorylated CTKD. Due to the presence of Ser380 phosphorylation, the PDK1-treated sample contained most of the phosphopeptides also identified from the ERK2 + PDK1-treated sample (CTKD, PDK1, and NTKD phosphosites) except for the ERK2 phosphorylation sites (i.e. 307, 369, 573, 637). The identified in vitro phosphorylation sites show a good match with the phosphorylation pattern yielded from high throughput data [24] . Only those Ser/Thr phosphorylation sites are highlighted which were identified in more than two independent high throughput analysis. (B) Cis autophosphorylation of the constitutive active CTKD. We observed strong autophosphorylation in an in vitro kinase assay (left). The C-terminal peptide phosphorylated on Ser732 was found in the trypsin digested active CTKD HPLC-MS/MS spectra (right). does not influence interaction with the MAGI-1 PDZ domain, confirming conclusions derived from the crystallographic analysis. However, the endothermic nature of binding between the PDZ domain and the longer RSK1 712-735 (or RSK1 696-735 ) peptide suggests that some degree of disordered-to-order transition occurs in the CTT upon phosphorylation. This local fold would likely be remodeled upon PDZ binding. A positively charged region of the MAPK-binding region is required for binding at the common docking (CD) groove of MAPKs [15] . As this region lies just next to the RSK1 autophosphorylation site, it is likely that the phosphorylated residues make electrostatic contacts to docking motif residues and thus affect PDZ and MAPK binding. Based on ITC measurements, DH showed linear decrease with increasing temperature, indicating that the signal is specific to peptide binding and is not biased by other temperature-dependent events such as thermal denaturation (Fig. 6B) . The change of heat capacity (DC p ) was estimated as the slope of a linear fit to the determined DH values between 10C and 37°C (Fig. 6 ). DC p is mainly proportional to changes in hydration upon binding [33] . Decrease in DC p indicates more extensive solvent exposed hydrophobic surface burial upon complex formation. Binding studies with the E6 peptide and the same PDZ construct showed that DC p increases (becomes less negative) if interactions outside the core motif or the core PDZ domain cannot form [32] . Because there is similar amount of amino acid burial in the minimal E6-PDZ and in the unphosphorylated RSK 729-735 -PDZ complex, they both display a similar DC p value (À150 calÁmol Unrestrained docking calculations from three independent starting structures were performed where the core interacting motif was derived from the protein-peptide crystal structure with an artificially built elongated C terminus. We found that the top calculations showed both dissociated and associated tails from the ERK2 docking surface. Lys729 was coordinated by the main chain of ERK2 in the cluster of associated tails (~50% of the calculated models suggesting that it is a small intramolecular clamp, possibly involving residues Nterminal to Lys729.
CTT structural dynamics in solution
In order to gain structural insights into the intramolecular clamp formed in the phosphorylated CTT, we applied NMR spectroscopy to characterize the native or phosphorylated CTT conformations and PDZ bound states in solution. The phosphorylated long RSK1 CTT peptide (696-735) was produced by CTKD phosphorylation in vitro. Changes in the 1 H-15 N HSQC spectra of RSK1 696-735 peptides confirmed that autophosphorylation by CTKD occurred only at Ser732 (Fig. 7A) . Despite phosphorylation, the secondary structure propensities remain highly similar compared to the unphosphorylated peptide and chemical shift mapping showed that Ser732 phosphorylation affected only the proximal residues (Fig. 7B) . Secondary chemical shifts (SCS) data demonstrated that the MAPK-binding linear motif region displays helical propensity, which is in good agreement with our previous observations [10] . Upon complex formation with the PDZ domain, the core interaction motif (the last five residues) became invisible in the NMR spectrum as a result of signal broadening confirming their central role in complex formation (Fig. 7C,D) .
Prolyl cis-trans isomerization is frequently found in disordered protein regions, not only in structured domains [34] . Usually minor peaks can be observed for cis-Pro surrounding residues (with~10% intensity compared to the corresponding major trans-peak) (Fig. 7E ). In the case of the unphosphorylated peptide, such minor peaks can be assigned to Leu730 and Ser732, which are next to cis-Pro731. In contrast, a considerably longer minor fragment (between residues 728-735) became apparent in the NMR spectrum of the phosphorylated peptide (Fig. 7F ). This region showed large beta propensity based on SCS values. Interestingly, the minor peak of Lys729 displayed similarly large chemical shift deviation upon phosphorylation as that of Ser732. Overall, this NMR data indicated significant chemical shift changes for residues of the charged motif (Arg725, Arg726, Arg728, and Lys729). Pro731 undergoes cis-trans isomerization and the chemical shift differences for Lys729 and Arg728 [32] . Note that DC p values obtained for RSK1 and E6 peptides are directly comparable as they were all determined using the same PDZ construct of MAGI-1. Asterisk indicates DC p values that were taken from Ref. [32] . are more prominent in the cis-Pro peptide, suggesting the existence of a more pronounced charge clamp specifically involving these latter two residues. Next, molecular dynamics (MD) simulations were used to further address the conformational dynamics of the CTT in different states. These computations also indicated the existence of conformationally distinct charge clamps in the CTT (Fig. 8A) . Various charge clamp interactions were found in either the trans-or cis-Pro731 peptides (Fig. 9) . MD trajectories showed that, despite that these interactions are dynamic, the negative charge of the phospho-residue could efficiently mask the MAPK binding charged motif. Cis-Pro can be considered as the core of type VI group b-turns and the stabilization of this b-turn conformation by phosphorylation is the likely reason why a larger cis-Pro containing minor fragment in the NMR data could be identified (Fig. 8B) .
Real-time monitoring of protein-protein interactions in living cells after EGF stimulation
After structural and biochemical characterization, we set out to address the impact of CTT autophosphorylation in living cells. We were particularly interested in the dynamics of the protein-protein interactions that RSK1 mediates with its partners (ERK2 and MAGI-1). Protein-protein interactions can be detected in cells by multiple methods; however, many of these lack the possibility of monitoring transient interactions as the reporter system significantly alters their behavior. A recent technique involving a novel split luciferase, called NanoBiT, was developed to monitor dynamic protein-protein association events in cells [35] (Fig. 10A) . This protein-fragment complementation assay includes two fragments: an 11-residue-long peptide fragment and a 18-kDa large fragment. We cloned RSK1 with the N-terminal peptide fragment and the other interaction partners with the large fragment attached to either their N or C terminus. We also made a single C-terminal residue-truncated RSK1 (DC1) incapable of PDZ binding, a mutant deficient in MAP kinase binding (L714E), and two other mutants, in which residues constituting the phosphorylationdependent charge clamp were mutated (S732A and K729A) (Fig. 10B) .
We found that the ERK2-RSK1 interaction was unaffected by DC1, but it was significantly reduced for the L714E mutant as expected (Fig. 10C) . We also monitored the MAGI-1-RSK1 interaction using the same technique. This interaction was decreased greatly by the C-terminal truncation (DC1), but it was unaffected by the other mutation designed to probe MAPK binding (Fig. 10G) . Interestingly, S732A and K729A mutations did not affect RSK1-MAGI-1 binding, while their association to ERK2 was greatly reduced. Next, we analyzed the effect of epidermal growth factor (EGF) on the ERK2-RSK1 and RSK1-MAGI-1 complexes in live cells (Fig. 10D,H) . Interestingly, EGF stimulation caused a moderate disassembly of the RSK1-MAGI-1 complex (~30% at the maximum), which was intact in the case of the K729A mutant (Fig. 10I,J) .
Upon EGF stimulation, a large drop in luminescence was observed for the ERK2-RSK1 complex, indicating the (partial) disassembly of the complex (Fig. 10E,F) . While all mutants displayed some stimulation-induced disassembly, we did not observe as large relative differences for S732A or K729A mutants compared with the wild-type protein, in contrast to an earlier study [11] . However, in that study, co-immunoprecipitation (co-IP) was used to monitor the dynamics of ERK2-RSK1 complex formation requiring cell lysis. This might have led to biased results because weak interactions are less detectable and the co-IP is not reliable if intracellular compartmentalization is an important factor that should be taken into account. Interestingly, some periodicity in the dissociation profiles appeared. Similar periodic kinetics was observed N HSQC spectra of the PDZ bound native RSK1 696-735 peptide (purple) and its phosphorylated form (red). Assignment of shifted peaks is shown. (D) Similarly to the changes caused by phosphorylation for the free peptide, there was no large conformation change in the peptide conformation and only small chemical shifts were observed for the terminal residues. The last four residues which are directly involved in PDZ binding became undetectable. Interestingly, the SCS values for residues neighboring the PDZ-binding region display a beta propensity, which may be the consequence of the clear beta conformation observed for the core motif in the protein-peptide crystal structure. (E) 1 
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N HSQC spectra of the free native RSK1 696-735 peptide (green) and its phosphorylated form (blue) showed with a lower cut-off compared to panel A. The assignment of minor peaks belonging to cis-Pro peptide conformations is indicated. The isomeric state of Pro residues is highlighted for Pro+1 residues. Gray labels show minor peaks which appear in both spectra without any change. (F) Analysis of the observed chemical shifts in the cis-Pro731 RSK1 CTT peptide. The sequence is underlined to indicate which residues showed clear minor peaks, for which the chemical environment changed upon prolyl isomerization. in ERK nuclear translocation [6] . Overall, this result suggests that stimulation-induced translocation may also have an impact on complex disassembly. Nevertheless, S732A and K729A mutants displayed a lower dynamic response.
Modulation of RSK and ERK cellular trafficking upon growth factor stimulation
After establishing that CTT autophosphorylation affects the dynamics of RSK-partner protein binding, we wanted to address how these observed dynamic changes relate to the proteins' movement between cellular compartments. For example, it is well known that ERK2 displays nuclear translocation upon EGF stimulation [6, 36] . We wanted to test whether RSK undergoes similar translocation or not. Endogenously expressed pan-RSK (RSK1/2/3) and pan-ERK (ERK1/2) were monitored in parallel experiments upon EGF stimulation using immunofluorescence (Fig. 11A) . We found that both proteins shift toward the nucleus upon stimulation with a highly similar time profile (Fig. 11B) . Next, the specific localization of the phosphorylated kinase species was examined using an anti-phospho RSK antibody developed against pSer380 and an anti-phospho ERK antibody developed against double phosphorylated pThr202/pTyr204. According to our results, pERK localized similarly to pan-ERK, but we also observed strong localization at the centrosomes during metaphase ( Figs 11C and 12 ) [37] . In contrast, pRSK localized strictly in the cytoplasm, whereas pan-RSK translocated mostly to the nucleus upon stimulation. These differences in the translocation trends of ERK and RSK show that they move independently during their activation and highlight the dynamically regulated nature of this signaling complex (Fig. 11D ).
Discussion
Monitoring protein-protein interactions in cells revealed dynamic changes in the assembly of ERK pathway-related signaling complexes How protein phosphorylation mechanistically contributes to the emergence of dynamic signaling complex assembly is not well-explored. By using a protein-protein interaction assay, which was specifically designed to allow the detection of dynamic protein-protein associations in living cells [35] , we monitored RSK1-ERK2 or RSK1-MAGI-1 binding and showed that RSK1 complex formation dynamically changes following EGF stimulation. The time between the ERK2-RSK1 dissociation spikes was 12-25 min, and the spikes had a rapid rise time (~6 min) and a slower decay time (≥ 9 min). Earlier, a similar oscillation profile for nuclear ERK shuttling or ERK phosphorylation was reported upon EGF stimulation [6] . In another work, similar but more sustained oscillation (with a mean periodicity of~100 min) was found after FGF stimulation in phosphorylated ERK or Ras-GTP levels [38] . The current model behind this periodic pattern under sustained stimulation postulates a negative feedback at an upstream level triggered by activated ERK. The observed independent localization trends of activated ERK and activated RSK (Fig. 11D ) and the charge clamp-based dissociation promoting effect of RSK1 CTT (Fig. 10F) can synergistically contribute to the periodicity and the amplitude of macroscopically observed pERK dissociation patterns. In addition, RSK phosphorylation (and probably nuclear localization) may also display an ERK-like periodic pattern because of its observed dynamic dissociation from MAGI-1. In summary, we found that the earlier reported dynamic pattern of ERK nuclear shuttling and activation shows an interesting agreement to the dynamics of some ERK controlled protein-protein complex formation events measured in our study. Thus, complex dynamic properties such as oscillations may already be apparent at the level of physical interactions between key components of the ERK pathway.
Oscillatory Ras/ERK activity, although its function remains enigmatic, has been proposed to be a novel molecular clock [38] . In addition, rapid biochemical oscillations, which do not require transcriptional level feedback, may be a means to selectively turn on a subset of genes controlled by the ERK pathway [39] . Similarly, the functional significance of the observed dynamic dissociation-association patterns remains to be elucidated. Nevertheless, our study provides the first glimpse on the way protein complex formation is dynamically regulated by a MAP kinase.
Classification of linear motif-based phosphoswitches
The CTT of RSK has several autophosphorylation sites. We found that the C-terminal autophosphorylation site of RSK1 is mainly Ser732, but the adjacent Thr residues may also be phosphorylated (Fig. 2) . RSK1 activation has a negative feedback on specific PDZ mediated interactions by directly interfering with the core motif. Interestingly, phosphorylation of Ser732 participates in the formation of a charged clamp, which affects ERK-RSK binding. Surprisingly, most of the phosphorylation sites identified in proteins do not have a dedicated role and cannot be considered as a regulatory switch [1, 5] . Nevertheless, phosphorylation, as a major post-translational regulatory mechanism, does trigger changes in the structure of proteins in various ways. A dominant class of switches induces intramolecular conformational changes. A wellknown example for this group is the activation loop of a kinase domain, which is disordered in the unphosphorylated state but gets ordered after phosphorylation, and then turns on the activity of the kinase domain. Phosphorylation can also trigger extreme changes in the global fold compared with simple loop remodeling as described above [40] . Interestingly, phosphorylation in or near linear-binding motifs located in disordered protein regions may achieve its effect by locally influencing the ability of a functional site to interact with a structured domain. Mechanistically, these linear motif-based phosphoswitches fall into different classes (Fig. 13) . There are simple ON and OFF switches and ON and OFF dimmers. For SH2 domains, Tyr phosphorylation is essential for peptide binding, thus an SH2 domain 
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The FEBS Journal 285 (2018) 46-71 ª 2017 Federation of European Biochemical Societies ligand may be regarded as an ON switch. In contrast, dimmers only adjust the interaction strength and can be considered as modulators. The PDZ domain of SNX27 binds to class I PDZ targets, where phosphorylation of position À2 disrupts the core interaction (OFF switch), whereas phosphorylation of either position À3, À5, or À6 increases the binding affinity by introducing new interactions (ON dimmer) [41] . OFF dimmers decrease binding affinity via intermolecular repulsion [42] . Other OFF dimmers may work mechanistically differently; they introduce an additional conformational selection step into the process of partner binding by using a charge clamp. Here, the phosphorylation triggers a transient local fold that can result in slowed-down conformational kinetics [43] . Similar intramolecular charge clamps have already been shown in some cases [44] [45] [46] ; however, the RSK1 CTT phosphoswitch appears to be the first clear case where it acts as a modulator on the assembly of a signaling complex. Since a conserved cluster of basic residues is a hallmark feature of nuclear localization signals or AGC kinase substrate motifs [24] , the functionality of these linear motifs involved in nuclear transport or AGC protein kinase-mediated phosphorylation, respectively, may also be modulated by adjacent phosphorylation sites.
Dynamic regulation is essential in maintaining the specificity and efficiency of signaling pathways [47] .
Here, we explored the mechanism underlying RSK Cterminal autophosphorylation and its role in affecting RSK1-ERK2 and RSK1-PDZ complexes. We found that the key element in these dynamically controlled association events is a disordered protein region, which is located outside the structured kinase domains of RSK1. The interaction of phosphorylated residues with positively charged residues in intrinsically disordered regions is likely to be a common mechanism of phosphoregulation. Moreover, linear motif-based phosphoswitches as described here may be frequently used, not only in kinase-substrates networks but also in other protein-protein interaction networks.
Experimental procedures
Protein expression and purification
All protein constructs were expressed in Escherichia coli Rosetta(DE3) pLysS (Novagen, Kenilworth, NJ, USA) cells with standard techniques. The expression and purification of ERK2 and the second PDZ domain of MAGI-1 are described in Refs [48] and [15] . Briefly, ERK2 was expressed with an N-terminal cleavable hexahistidine tag which was removed after affinity purification. MAGI-1 was expressed with a TEV cleavable N-terminal hexahistidine-MBP fusion tag. After Ni-and MBP-affinity purification, the reaction mixture was reloaded onto Ni-agarose and the Fig. 13 . Classification of linear motif-based switches modulated by phosphorylation. In case of a classical phosphoswitch, phosphorylation alters the binding properties of the linear motif. There are ON and OFF switches and ON and OFF dimmers. For the latter, changes in binding affinity are less dramatic and dimmers only adjust the interaction strength, where phosphorylation either increases it (ON) or dampens it (OFF). Charge clamps have a similar effect as OFF dimmers, but they achieve their dampening effect via a distinct mechanism, which is more indirect compared to that of classical dimmers. Phosphorylation mediates intramolecular interactions in their free disordered state, which then represents a kinetic barrier for their binding to interaction partners.
flow-through was further purified on a Superdex 75 (GE Healthcare, Little Chalfont, UK) gel filtration column. Unphosphorylated RSK1 peptides (696-735 or 370-385) were produced as formerly described in Ref. [13] A chimeric PDZ domain-annexin A2 protein was cloned with a removable N-terminal hexahistidine tag into a modified pET15 expression plasmid. TEV protease cleavage leaves an extra GSM linker at the N terminus of the PDZ domain. The construct contained the second PDZ domain of MAGI-1 (455-558) connected by a two amino acid long 'GS' linker to the core annexin A2 domain (ANXA2, . This fusion protein was expressed using an autoinduction-based protein expression method. The produced protein was purified on Ni-agarose beads, and the affinity tag was cleaved off by TEV protease cleavage. The protein was further purified on an SP ion exchange column at pH 6.5 using a linear gradient from 20 mM NaCl to 1 M NaCl in the presence of 2 mM TCEP. The final sample was eluted at~20% and was concentrated to 330 lM concentration. Crystallization samples were supplemented with 2 mM TCEP, 10% glycerol and 2 mM CaCl 2 before the aliquots were frozen in liquid nitrogen.
Kinase reactions
For phosphopeptide mapping, 3 lM GST-RSK1 in the presence or absence of 3 lM GST-PDK1 and 1 lM activated ERK2 was incubated at 32°C for 1 h with 250 lM ATP. The mixture was separated by SDS/PAGE and the protein band corresponding to RSK1 was cut from the gel for MS studies. Gel slices were treated based on Ref. [49] . In vitro phosphorylation of RSK1 (370) (371) (372) (373) (374) (375) (376) (377) (378) (379) (380) (381) (382) (383) (384) (385) was carried out with CTKD or with the T573E mutant CTKD in the presence of 250 lM ATP and~5 lCi of [c-32 P] ATP. Reactions were stopped with protein loading sample buffer complemented with 20 mM EDTA, boiled and then subjected to SDS/PAGE. The gel was dried and then analyzed by phosphorimaging on a Typhoon Trio+ scanner (GE Healthcare). Sample preparation for MS of the T573E mutant CTKD was identical with the previously described method.
In vitro phosphorylation of unlabeled or 15 N-and 13 Clabeled RSK1 peptides (100-150 lM) were carried out in the presence of the constitutively active CTKD (5 lM), 1 mM ATP, 5 mM MgCl 2 , and 1 mM TCEP at 37°C for 3 h. Phosphorylated peptides were purified by HPLC on a C5 reversed-phase column.
Phosphopeptide mapping and mass spectrometry
Protein sample characterization was performed using a Maxis II ETD QqTOF instrument (Bruker Daltonics, Billerica, MA, USA) coupled to an Ultimate 3000 nanoRSLC system (Dionex, Sunnyvale, CA, USA) under the control of HYSTAR v.3.2 (Bruker Daltonics). Samples were dissolved in 12 lL of 2% acetonitrile and 0.1% formic acid; 3 lL sample was injected onto an Acclaim PepMap100 C-18 trap column (100 lm 9 20 mm; Thermo Scientific). Peptides were separated on an ACQUITY UPLC M-Class Peptide BEH C18 column (130 A, 1.7 lm, 75 lm 9 250 mm; Waters, Milford, MA, USA). Raw data were recalibrated using the COMPASS DATAANALYSIS software 4.3 (Bruker Daltonics). Samples were matched with the RSK1 sequence using the MASCOT server v.2.5 (Matrix Science, Boston, MA, USA. The parameters for the Mascot search were set as follows: trypsin digestion where maximum two missed cleavages were allowed and cysteine carbamidomethylation as fixed and oxidation (M), deamidation (NQ), and phosphorylation (ST) as variable modifications. Precursor tolerance was set to 7 ppm, the MS/MS tolerance was 0.05 Da.
ESI-MS measurements of isolated peptides were carried out on a Bruker Daltonics Esquire 3000plus ion trap mass spectrometer using direct sample infusion or online HPLC coupling. For direct analysis, samples were dissolved in 50% acetonitrile and 0.1% acetic acid. HPLC separations were performed on a Jasco PU-2085Plus HPLC system using a Supelco Ascentis C 18 column (2.1 mm 9 150 mm, 3 lm), which was directly coupled to the mass spectrometer. Enzymatic digestion was performed by trypsin (Promega Trypsin Gold, MS grade), using a protein/enzyme ratio of 100 : 1 (w/w) in 10 mM ammonium acetate buffer. In all cases, collision-induced dissociation experiments were used for peptide sequencing.
Binding experiments
Fifty nanomolar reporter peptide (RSK1 712-735 peptide fluorescein-conjugated at the N terminus) was mixed with increasing amounts of ERK2 or MAGI-1 in fluorescence polarization (FP)-based titration experiments and the FP signal was measured with a Synergy H4 (BioTek Instruments, Winooski, VT, USA) plate reader in 384-well plates. In competitive FP measurements, 50-nM labeled reporter peptide was mixed with ERK2 in a concentration to achievẽ 60-80% complex formation. Subsequently, increasing amounts of unlabeled peptide constructs were added. The K D for each experiment was determined by fitting the data to a quadratic or a competition-binding equation. Titration experiments were carried out in triplicates and the average FP signal was used for fitting the data with ORIGINPRO 7 (OriginLab, Northampton, MA, USA).
Microscale thermophoresis was measured in standard coated capillaries in 20 mM Hepes pH 7.5, 150 mM NaCl, 0.5 mM TCEP, and 0.05% Tween on a Monolith NT.115 instrument (Nanotemper Technologies, Mu¨nchen, Germany). We found that the uncleaved MBP fusion protein was more suitable for these measurements than the isolated PDZ domain and the highest signal was achieved by using an N-terminally labeled RSK1 729-735 peptide as a reporter. In competitive binding experiments, the complex was mixed to achieve near saturation and either unlabeled unphosphorylated or phosphorylated RSK1 729-735 was used as a competitor. Experiments were performed at 22°C, 50% LED output, 60% IRlaser power using the fluorescent peptide at constant 50 nM concentration.
Isothermal titration calorimetry (ITC) measurements were carried out in 20 mM Hepes pH 7.5, 150 mM NaCl, and 0.5 mM TCEP using an ITC200 or a VP-ITC apparatus (MicroCal, Worcestershire, UK); 50-100 lM PDZ domain was titrated with 0.8-2 mM RSK1 peptides at 10, 20, 30, or 37°C. The ORIGIN for ITC 5.0 (OriginLab) software package was used for data processing and data were fitted with a model 'One Set of Sites'. Heat capacity changes (JÁmol À1 ÁK À1 ) were calculated based on the empirical formula: DC p = 2.14*DASA apol À 0.88*DASA pol , where DASA apol and DASA pol are the apolar and polar accessible surface area changes ( A 2 ), respectively.
Crystal structure determination of CTT(RSK1)-PDZ(MAGI-1) complexes
To determine the high-resolution structure of the interaction of RSK1 peptide-MAGI-1 PDZ domain, we tried to crystallize the complex at high concentration (> 3-5 mM) using various commercially available crystallization screens. Despite these efforts, no crystals grew and even precipitations were scarce in the crystallization drops. In order to determine the structure of this protein-peptide complex, we tried a carrier-protein-driven crystallization strategy, but instead of using existing fusion tags such as MBP, GST, or thioredoxin, we used the core domain of annexin A2 (ANXA2) [50] . ANXA2 is a calcium-binding perimembrane protein with excellent crystallization properties, good solubility, and stability [51] . The diffraction datasets were collected on the P14 beamline at EMBL Hamburg and on the PXIII beamline at SLS. The phase problem was solved by molecular replacement with Phaser using PDB entry 1XJL and 2KPK as starting models [31, 50, 52 ]. Structure refinement was carried out using PHENIX, and structure remodeling and building were performed in Coot [53, 54] . Structure solution revealed two molecules in the asymmetric unit where crystal packing interactions are mainly formed by ANXA2 ( Table 1 ). The short linker (a single Gly-Ser) between the ANXA2 fusion tag and the PDZ domain allowed some flexibility in domain arrangements, but one of the PDZ domains mediated important crystal packing contacts, which stabilized its location in the asymmetric unit. This was apparently important in detecting the RSK1 peptides in the canonicalbinding pocket of one of the PDZ domains, while the electron density map around the other PDZ domain remained poorly visible.
NMR measurements
NMR spectra were recorded on a Bruker Avance III 700 spectrometer operating at 700. [55] . The probability of proline to be in cis form was calculated by integration of HSQC peak intensity. Secondary chemical shift values were determined based on Ref. [56] . Chemical shift variations upon phosphorylation and interaction with the PDZ domain were calculated with the formula:
. Assignation of the native and phosphorylated RSK1 peptides were deposited to the BMRB database under the accession codes 27213 and 27214.
Molecular dynamics simulations
All-atom MD simulations were executed with GROMACS, version 5.1.4 program package [57] using AMBER99SB*-ILDNP force field [58] with neutralizing Na + counter ions and TIP3 explicit solvent molecules [59] . The length of the unrestrained simulations was 300 ns in all cases. The starting model of trans conformers were created using the MAPK bound conformation (PDB ID: 4NIF) where the invisible C-terminal amino acids were built in an extended conformation. The starting model of cis conformers were created similarly, but with a C terminus in a VIa1 b-turn conformation. Peptide cis conformation was stable during the whole simulation. The energy-minimized systems were subjected to MD calculations with a time step of 2 fs at a constant temperature of 300 K. The resulting trajectory files were analyzed with programs of the GROMACS package.
Protein-protein interaction assay
The NanoBiT PPI MCS starter system was purchased from Promega (Madison, WI, USA). Full-length RSK1 was cloned into pBit2 2 -independent medium (Thermo Scientific). Cells were assayed 24 h after transfection using Nano-Glo reagent (Promega) and a Synergy H4 plate reader (BioTek). Experiments were carried out according to the manufacturer's instructions. Stimulation was performed using 100 ngÁmL À1 EGF (SigmaAldrich, Saint Louis, MO, USA). For detection of transfection efficiency of point mutants, cells were suspended in PBS and samples were subjected to western blot using anti-RSK1/2/3 antibody (1 : 500; CST) and anti-a-tubulin (1 : 5000; Sigma).
Immunofluorescence
For detection of endogenous protein localization, 1 9 10 5 cells per well were seeded onto a cover slip-containing (Assistent) 24-well plate. Cells were serum-starved prior to EGF stimulation. After stimulation, cells were fixed with 4% PFA solution and blocked for 1 h in 5% BSA and 0.3% Triton-X in PBS at room temperature. Staining of ERK1/2 and RSK1/2/3 was performed using anti-ERK1/2 (1 : 800; CST) and anti-RSK1/2/3 (1 : 100; CST), respectively. Phosphorylated proteins were detected with anti-pRSK pSer380 (1 : 800; CST) or anti-pERKpThr202/pTyr204 (1 : 250; CST). Tubulin staining was performed with anti-a-tubulin (1 : 1000; Sigma). Secondary antibodies were conjugated with Alexa Fluor 647 (anti-rabbit, 1 : 800; Thermo) and Alexa Fluor 488 (anti-mouse, 1 : 500; Thermo). Nuclear staining was performed using DAPI (0.1 lgÁmL À1 ). After washing, cover glasses were mounted to microscopy slides by Mowiol 4-88 mounting medium (Sigma). Confocal microscopy was carried out using a Zeiss LSM 710 system (Carl Zeiss Microscopy GmbH, Jena, Germany) with a 409 oil objective. Images were processed by the IMAGEJ software.
